PRGO

PRGO

USD

Perrigo Company plc Ordinary Shares

$20.190-0.300 (-1.464%)

Preço em tempo real

Healthcare
Drug Manufacturers - Specialty & Generic
Irlanda

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$20.490

Máximo

$20.620

Mínimo

$20.180

Volume

12.00M

Fundamentos da empresa

Capitalização de mercado

2.8B

Setor

Drug Manufacturers - Specialty & Generic

País

Ireland

Estatísticas de negociação

Volume médio

1.94M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $20.18Atual $20.190Máximo $30.93

Notícias relacionadas

PR Newswire

Perrigo to Attend Jefferies Consumer Conference

Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that President and CEO Patrick Lockwood-Taylor and...

Ver mais
Reuters

Drugmakers must face skincare drug price-fixing lawsuit, US judge rules

A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix prices of 80 generic drugs.

Ver mais
Drugmakers must face skincare drug price-fixing lawsuit, US judge rules
PR Newswire

Perrigo Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer health products, today announced that its Board of Directors declared a...

Ver mais
Perrigo Announces Quarterly Dividend
Analyst Upgrades

Jefferies Maintains Hold on Perrigo, Lowers Price Target to $23

Jefferies analyst Keith Devas maintains Perrigo with a Hold and lowers the price target from $27 to $23.

Ver mais
Jefferies Maintains Hold on Perrigo, Lowers Price Target to $23
PR Newswire

Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2025...

Ver mais
Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025